RAVERA, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 6.997
EU - Europa 6.496
AS - Asia 3.894
SA - Sud America 704
Continente sconosciuto - Info sul continente non disponibili 225
AF - Africa 133
OC - Oceania 7
Totale 18.456
Nazione #
US - Stati Uniti d'America 6.780
RU - Federazione Russa 1.694
IE - Irlanda 1.387
SG - Singapore 1.169
CN - Cina 1.017
DE - Germania 841
SE - Svezia 692
HK - Hong Kong 605
UA - Ucraina 548
BR - Brasile 537
VN - Vietnam 535
IT - Italia 421
FI - Finlandia 352
FR - Francia 249
IN - India 162
CA - Canada 128
GB - Regno Unito 124
BD - Bangladesh 82
AR - Argentina 63
KR - Corea 59
MX - Messico 50
ID - Indonesia 43
BJ - Benin 40
PL - Polonia 39
ZA - Sudafrica 39
IR - Iran 37
EC - Ecuador 33
TR - Turchia 32
ES - Italia 28
JP - Giappone 27
BE - Belgio 23
CO - Colombia 20
IQ - Iraq 19
NL - Olanda 19
AT - Austria 18
PK - Pakistan 18
CL - Cile 16
LT - Lituania 15
UZ - Uzbekistan 15
EG - Egitto 14
VE - Venezuela 14
MA - Marocco 11
RO - Romania 11
EU - Europa 10
SA - Arabia Saudita 10
JM - Giamaica 9
PY - Paraguay 9
JO - Giordania 8
NP - Nepal 7
TH - Thailandia 7
TN - Tunisia 7
AL - Albania 6
AU - Australia 6
CR - Costa Rica 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
HR - Croazia 5
IL - Israele 5
UY - Uruguay 5
AZ - Azerbaigian 4
CH - Svizzera 4
HN - Honduras 4
KE - Kenya 4
PA - Panama 4
BG - Bulgaria 3
BO - Bolivia 3
CI - Costa d'Avorio 3
ET - Etiopia 3
NG - Nigeria 3
OM - Oman 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
CG - Congo 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HU - Ungheria 2
KZ - Kazakistan 2
MD - Moldavia 2
NI - Nicaragua 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BZ - Belize 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
GD - Grenada 1
GY - Guiana 1
KG - Kirghizistan 1
Totale 18.226
Città #
Dublin 1.379
Jacksonville 994
Hong Kong 602
San Jose 578
Dearborn 542
Singapore 473
Ashburn 422
Council Bluffs 367
Beijing 308
New York 266
Chandler 253
Wilmington 237
Moscow 218
Los Angeles 185
Lauterbourg 176
Ho Chi Minh City 173
Lawrence 173
Princeton 173
Ann Arbor 160
San Mateo 128
Columbus 116
Hanoi 114
Andover 108
Piemonte 104
Buffalo 94
Munich 80
Santa Clara 72
São Paulo 64
Toronto 63
Dallas 55
Seoul 54
Orem 51
Grafing 48
Bremen 43
Novara 41
Cotonou 40
Frankfurt am Main 37
Redondo Beach 37
Denver 33
Helsinki 33
Houston 33
Hefei 32
Chicago 31
Montreal 30
Nanjing 30
Atlanta 29
Warsaw 28
Chennai 26
Da Nang 25
Woodbridge 25
Brooklyn 24
Guangzhou 24
Mexico City 24
Tokyo 24
Boardman 23
Kunming 23
Haiphong 22
Monmouth Junction 22
Stockholm 22
Norwalk 21
Brussels 20
Leawood 20
Cave Creek 19
Hangzhou 19
Johannesburg 19
London 19
Rio de Janeiro 19
Milan 18
Biên Hòa 16
Manchester 16
Mumbai 16
Nuremberg 16
Zanjan 16
Phoenix 15
Tashkent 15
Tianjin 15
Turin 15
Poplar 14
Shanghai 14
Belo Horizonte 13
Fairfield 13
Ardabil 12
Augusta 12
Boston 12
Hải Dương 12
San Francisco 12
Seattle 12
Ankara 11
Brasília 11
Jinan 11
Kocaeli 11
Philadelphia 11
Quito 11
Turku 11
Amsterdam 10
Guayaquil 10
Hebei 10
Jakarta 10
Ninh Bình 10
Rome 10
Totale 10.168
Nome #
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen 169
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 161
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 154
A view on multi-action Pt(IV) antitumor prodrugs 154
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 152
Transition metal carbonyl clusters in biology: A futile or niche research area? 147
Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling 146
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 144
Assessment of the anticancer potentiality of a new platinum nanoparticulate coniugate 142
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 142
A different way for the oxidation of the Pt(II) complexes 141
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 141
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 139
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 139
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 139
Antiproliferative Activity of PtII Complexes with Carboxylated Phosphanes in Chelated or Ring-Opened Forms 138
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 136
Appraisal of the Redox Behaviour of the Antimetastatic Ruthenium(III) Complex [ImH][RuCl4(DMSO)(Im)], NAMI-A 136
Different strategies to exploit Pt(IV) complexes as pro-drugs 135
A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives 135
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 134
New Platinum-Based Prodrug Pt(IV)Ac-POA: Antitumour Effects in Rat C6 Glioblastoma Cells 134
Antitumor platinum(IV) pro-drugs: synthesis, characterization, cytotoxicity and QSAR analysis 133
A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination 133
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 133
How to obtain Pt(IV) complexes suitable for conjugation to nanovectors from the oxidation of [PtCl(terpyridine)]+ 133
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 132
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 131
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 129
Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines 129
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 128
Application of microwave-assisted heating to the synthesis of Pt(II) complexes 128
Cytotoxicity of some Pt(II)-diamine complexes: a QSAR evaluation of the effect of chelating arms and leaving groups 125
Estradiol as Carrier For Selective Delivery of Cytotoxic Pt(II) Complexes to Cancer Cell Nuclei 124
Experimental (RP-HPLC) and theoretical (MIFs) study of the lipophilicity of a series of Pt(IV) complexes 124
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 122
Experimental and molecular modeling approaches to determine the lipophilicity of a Pt(IV) pro-drugs 119
Electrochemical measurements confirm the preferential bonding of the antimetastatic complex [ImH][RuCl(4)(DMSO)(Im)] (NAMI-A) with proteins and the weak interaction with nucleobases 119
Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(iv) complexes to obtain antiproliferative agents against human glioblastoma cells 118
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 117
Effects of dimethylsulfoxide and ethanol on the cytotoxic activity of titanocene dichloride 117
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 117
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 115
Freshening up Old Methods for New Students: A Colorful Laboratory Experiment to Measure the Formation Constants of Ni(II) Complexes Containing Ethane-1,2-Diamine 115
Anthracene-terpyridine metal complexes as new G-quadruplex DNA binders 114
Synthesis of PtIV-Biomolecule Conjugates through Click Chemistry 114
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 113
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 113
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 113
Classical Pt(II) anticancer complexes revised in view of drug targeting and delivery 112
Oxidative degradation of 1,5-naphthalenedisulfonic acid (NDS) in aqueous solutions by microwave irradiation in the presence of H2O2 112
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 112
Solvolysis of a Series of Cisplatin-Like Complexes – Comparison between DNA-Biosensor and Conductivity Data 111
Electronic Communication in [Co2(CO)6]2-diyne and [Co2(CO)4(dppm)]2-diyne Complexes 110
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 110
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 110
Pt(iv) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activity 110
An experiment in the electrokinetic removal of copper from soil contaminated by the brass industry 109
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 109
Molecular Interaction Fields vs. Quantum-Mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes 108
Prediction of logP for Pt(II) and Pt(IV) complexes: Comparison of statistical and quantum-chemistry based approaches 106
Bioinorganic chemistry: the study of the fate of platinum-based antitumour drugs 105
A comparative study of the effects of platinum(II) complexes on β-amyloid aggregation: Potential neurodrug applications 105
Characterization of 37 enological tannins using a multiple technique approach: Linear sweep voltammetry as a rapid method both for classification and determination of antioxidant properties 104
Revisiting [PtCl2(cis-1,4-DACH)]: An Underestimated Antitumor Drug with Potential Application to the Treatment of Oxaliplatin-Refractory Colorectal Cancer 104
Pt(IV) complexes as anticancer prodrugs 104
Electrochemical Behavior of the Electronically and Coordinatively Unsaturated [Os3(µ-H)(CO)8{Ph2PCH2P(Ph)C6H4}] Cluster 103
Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake? 103
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 102
Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex 102
Unsymmetric cisplatin-based pt(Iv) conjugates containing a parp-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines 102
Pt(IV)/Re(I) Chitosan Conjugates as a Flexible Platform for the Transport of Therapeutic and/or Diagnostic Anticancer Agents 101
Pyrazolyl-diamine Pt(II) complexes bearing DNA-intercalating moieties: Synthesis, characterization and in vitro evaluation 99
Oxidative degradation of 1,5-naphthalenedisulfonic acid in aqueous solutions by UV-photolysis in the absence and presence of H2O2 99
trans,cis,cis-Bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin-Refractory Colorectal Cancer 99
Bifunctional Ethacrynic Acid – Pt Conjugates: In vitro Treatment of Malignant Pleural Mesothelioma 98
Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes 98
Electrochemical Biosensor Assay of the Interaction between [PtCl(n)(NH(3))(4-n)]((2-n)) (n=0-4) Complexes and ds-DNA 98
New strategies to overcome therapeutic resistance in glioblastoma 98
Solvolysis of Cisplatin and N-Methylated cis-[PtCl2(en)] Complexes – Comparison between DNA-Biosensor and Conductivity Data 97
Inhibition of telomerase activity by platinum derivatives 96
Conjugation between maleimide-containing Pt(IV) prodrugs and furan or furan-containing drug delivery vectors via Diels-Alder cycloaddition 95
Bidentate and tridentate pyrazolyl-containing Pt(II) complexes: synthesis, characterization and in vitro evaluation 93
Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies 93
Electrochemical, Theoretical and Structural Investigations on the "Butterfly" Co4(CO)8L2(RC2R) (L=CO, PPh3, R=H, Et, Ph) Cluster 93
Carbonylation of Alkynes Catalyzed by Iron Carbonyls. A Reinvestigation of the Mechanism of the Formation of Fe2(CO)6[(EtC=CEt)CO2] 93
Stabilization of carbenium ions derived from ethynylestradiol by different adjacent organometallic moieties. Implication in the inactivation of the estrogen receptor 92
Electron Interactions in Cluster Dimers. An Electrochemical Approach 91
Studies on Log Po/w of Quinoxaline di-N-Oxides: A Comparison of RP-HPLC Experimental and Predictive Approaches 91
Over 100 Years of Research on Cyclopentadienylironcarbonyl Chemistry: Microscale-Integrated Organometallic Experiments 90
Synthesis and in-vitro cytotoxicity of cis,cis,trans-diammine dichlorido disuccinatoplatinum(IV)-peptide bioconjugates 89
The activation of platinum(II) antiproliferative drugs in carbonate medium evaluated by means of a DNA-biosensor 89
A Phyto-mycotherapeutic Supplement, Namely Ganostile, as Effective Adjuvant in Brain Cancer Management: An In Vitro Study Using U251 Human Glioblastoma Cell Line 88
Experimental determination and modeling of the lipophilicity in platinum complexes 88
Targeting and delivery of Pt(II) antiproliferative drugs 88
The Stepwise Reduction of Dinitrogen Occurring on a Divanadium Model Compound: A Synthetic, Structural, Magnetic, Electrochemical and Theoretical Investigation on the [V=N=N=V]n+ [n = 4, 5, 6] Based Complexes 87
Electron Interactions in Cluster Diynes. An Electrochemical Approach 86
The Microscale Synthesis and Electrochemistry of Low-Valent Mononuclear Complexes (h3-C3H5)Fe(CO)3X (X = I, Br, Cl) 86
Pt(iv) antitumor prodrugs: dogmas, paradigms, and realities 85
Estrogenic carriers for cytotoxic Pt(II) complexes: light and shade 84
Totale 11.503
Categoria #
all - tutte 93.727
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.727


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.151 0 20 171 141 57 0 161 28 80 22 214 257
2022/20232.614 186 93 170 65 147 244 55 134 1.377 34 77 32
2023/2024763 54 62 76 14 138 0 136 11 9 4 132 127
2024/20251.763 17 53 99 42 74 188 197 98 389 210 83 313
2025/20267.237 372 318 589 1.103 594 485 1.021 1.215 505 484 357 194
2026/2027768 318 450 0 0 0 0 0 0 0 0 0 0
Totale 18.456